Scientists identify protein which could improve treatments for recurrent miscarriagesMay 13, 2016
Scientists at the University of Sheffield have identified a protein, involved in the development of the human placenta, may also help embryos implant in the womb - something which could improve treatments for recurrent miscarriages and pre-eclampsia.
The pioneering study shows that a protein called Syncytin-1, which was the result of a viral infection of our primate ancestors 25 million years ago, is first secreted on the surface of a developing embryo even before it implants in the womb.
This means the protein is likely to play a major role in helping embryos stick to the womb as well as the formation of the placenta.
This fundamental understanding of the earliest stages of human embryo development is crucial for improving current treatments for a variety of stressful complications during pregnancy such as recurrent miscarriages, foetal growth restriction syndrome and pre-eclampsia - a life-threatening condition of elevated maternal blood pressure during pregnancy.
Professor Harry Moore, Co-Director for the University's Centre for Stem Cell Biology and lead author of the study, said: "Recurrent miscarriages, foetal growth restriction syndrome and pre-eclampsia are all significant and very stressful complications of pregnancy.
"Eventually we may be able to develop blood tests based on our results to identify pregnancies that might be at risk and also develop appropriate therapies.
"There is a lot on the news about the Zika virus infection at the moment and its devastating effects on foetal development but not all viral infections are necessarily as disastrous. "
He added: "Amazingly the Syncytin-1 gene is the result of a viral infection of our primate ancestors 25 million years ago. The viral DNA got into our ancestors genome and was passed on through heredity and the gene involved in the fusion of the virus with cells for infection was co-opted and became Syncytin-1. Without it humans probably would not have evolved."
Surprisingly scientists know much more about the processes of early embryo development in animals than they do in humans. However, embryo development and reproduction is an aspect of biology where there are fundamental differences between species.
Researchers will now investigate whether the level of Syncytin-1 secretion on the pre-implantation embryo is somehow related to outcome of pregnancy in women undergoing IVF.
"Until now we didn't know this protein was expressed so early in the embryo.
"Interestingly the Syncytin-1 protein was mainly secreted in the cells of the embryo, called polar trophoblast cells, which will first stick to the cells of the womb called endometrial epithelial cells.
"In the lab we discovered the trophoblast cells that secrete Syncytin-1 not only fuse together - which in the body will form an essential barrier to protect the embryo - but also secrete nano-vesicles called exosomes.
"These exosomes may communicate with cells in other areas of the mother to prepare her for pregnancy. If this doesn't happen properly at the earliest stages it may cause problems throughout pregnancy."
The study is published today (Friday 13 May 2016) in the journal Human Reproduction .
 "Expression of Syncytin I (HERV-W), in the preimplantation human blastocyst, embryonic stem cells and trophoblast cells derived in vitro", by Bikem Soygur and Harry Moore. Human Reproduction, doi:10.1093/humrep/dew097.
The University of Sheffield
With almost 27,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world's leading universities. A member of the UK's prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines. Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in. Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2016 and was voted number one university in the UK for Student Satisfaction by Times Higher Education in 2014. In the last decade it has won four Queen's Anniversary Prizes in recognition of the outstanding contribution to the United Kingdom's intellectual, economic, cultural and social life. Sheffield has five Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields. Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.
For further information, please visit http://www.sheffield.ac.uk
University of Sheffield
Related Recurrent Miscarriages Current Events and Recurrent Miscarriages News Articles
Body clock genes could hold key to recurrent miscarriages
Researchers at the University of Warwick and UHCW have discovered how body clock genes could affect women's ability to have children.
Failed synchronization of the womb's clock with mother's body clock critical in miscarriages
If you are trying to have a baby, a good night's sleep is more important than ever. A new research report appearing in The FASEB Journal shows that the womb has its own "body clock" that needs to synchronize with the mother's body clock to ensure optimal conditions for fetal growth and development.
What makes a successful pregnancy?
Fertility problems, recurrent miscarriages, and pregnancy complications can occur when maternal immunological tolerance of the fetus is impaired.
Faulty molecular switch can cause infertility or miscarriage
Scientists have discovered an enzyme that acts as a 'fertility switch', in a study published in Nature Medicine today. High levels of the protein are associated with infertility, while low levels make a woman more likely to have a miscarriage, the research has shown.
Women with polycystic ovary syndrome have higher BPA blood levels
Women with the polycystic ovary syndrome (PCOS), the most common hormone imbalance in women of reproductive age, may be more vulnerable to exposure to the chemical bisphenol A (BPA), found in many plastic household items, according to a new study. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.
Complications early in pregnancy or in previous pregnancies adversely affect existing or subsequent pregnancies
Complications in early pregnancy or in previous pregnancies can predict the likelihood of further problems in current or subsequent pregnancies, according to research carried out by an international group of experts.
Women are more likely to suffer recurrent miscarriages if their first child is a boy
Women who give birth to a boy as their first child are more likely to suffer subsequent miscarriages than women whose first baby is a girl, an international conference of fertility experts heard today (Tuesday 1 July). Dr Ole Christiansen, a consultant registrar at the Rigshospitalet Fertility Clinic in Copenhagen, Denmark, told the annual conference of the European Society of Human Reproduction and Embryology, that giving birth to a boy first was not only a risk factor for subsequent miscarriages, but for women who suffered unexplained secondary recurrent miscarriages (SRM) it could mean that they never managed to carry a child to full term again unless doctors gave them appropriate treatme
PGD could save women from the agony of repeated miscarriages
Women who suffer repeated unexplained miscarriages can be helped to have babies if preimplantation genetic diagnosis (PGD) is carried out on their embryos before they are placed in the womb. Ms Carmen Rubio told the European Society of Human Reproduction and Embryology annual conference in Vienna today (Monday 1 July) that her research showed that chromosomal abnormalities (aneuploidies) in the embryos were important causes of unexplained recurrent miscarriages (RM) and implantation failure (IF). She and her colleagues had achieved normal pregnancy rates and a decreased risk of miscarriage in women with these conditions by screening the embryos for chromosomal abnormalities during IVF and tr
UK researchers shed new light on a cause of recurrent miscarriages
Women who carry a particular genetic mutation that predisposes them to blood clots have a significantly higher chance of miscarrying, according to UK researchers in a report (Wednesday 30 January) in Europe's leading reproductive medicine journal Human Reproduction.* The first prospective study into the outcome of untreated pregnancies in a group of women carrying a mutation in the Factor V Leiden gene** and with a history of recurrent miscarriages at around 12 weeks, showed that under 40% had live births compared with nearly 70% in a control group of women with a similar history but with a normal copy of the gene. For women with the rogue gene who had a history of late miscarriage only one
RECURRENT MISCARRIAGE AND FETAL GROWTH RETARDATION ASSOCIATED WITH COELIAC DISEASE (p 399)
Coeliac disease - a condition where wheat gluten causes dietary malabsorption to genetically-susceptible individuals - may be closely linked to recurrent spontaneous abortion or intrauterine growth retardation, according to a research letter published in this week's issue of THE LANCET. 15% of pregnancies result in spontaneous abortion, with the underlying cause being known in less than 60% of cases. Antonio Gasbarrini and colleagues from Gemelli Hospital, Rome, Italy, aimed to assess the frequency of latent or subclinical (symptomless) coeliac disease by blood testing and intestinal biopsy samples in women with a history of recurrent spontaneous abortion (RSA), or intrauterine growth retard
More Recurrent Miscarriages Current Events and Recurrent Miscarriages News Articles